Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03

PURPOSE: A phase I, dose-finding study of vorinostat in combination with temozolomide (TMZ) was conducted to determine the maximum tolerated dose (MTD), safety, and pharmacokinetics in patients with high-grade glioma (HGG). EXPERIMENTAL DESIGN: This phase I, dose-finding, investigational study was c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lee, Eudocia Q., Puduvalli, Vinay K., Reid, Joel M., Kuhn, John G., Lamborn, Kathleen R., Cloughesy, Timothy F., Chang, Susan M., Drappatz, Jan, Yung, W. K. Alfred, Gilbert, Mark R., Robins, H. Ian, Lieberman, Frank S., Lassman, Andrew B., McGovern, Renee M., Xu, Jihong, Desideri, Serena, Ye, Xiabu, Ames, Matthew M., Espinoza-Delgado, Igor, Prados, Michael D., Wen, Patrick Y.
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947570/
https://ncbi.nlm.nih.gov/pubmed/22923449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1841
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares